Research: Drug Pricing Models Key to Pharma Success; Value Demonstration is Crucial Beyond Patent Expiration

Pharmaceutical companies must understand complex drug pricing models to achieve market success, according to recent research. Key elements of these models include preparing for patent expirations, adapting to value-based pricing, and utilizing data analysis. The research also suggests companies need to understand the impact of biosimilars, generic competition, and emerging market trends. The study highlights that pharmaceutical firms must look beyond patent expirations and consider the broader pricing environment. To effectively demonstrate product value in the evolving healthcare landscape, companies need to show the cost-effectiveness, quality of life improvements, and patient outcomes of their products. Researchers suggest these organizations leverage data to inform pricing strategies, find new market opportunities, and streamline supply chains in order to maintain a competitive edge.

Newsflash | Powered by GeneOnline AI
Date: April 14, 2025

Related posts:

Training in Future Thinking Proven to Reduce Impulsivity, Enhance Decision-Making Study Identifies Brain Circuits Linking Empathy to Behavioral Responses AI Analyzes Drug Data, Showing Promise for Alzheimer’s, Parkinson’s, and Multiple Sclerosis Treatments Latin American Generic Drug Market Faces Regulatory Hurdles, Projected to Reach $14.6 Billion by 2025

Author

Mark Chiang

紐約 NYU Computer Science 碩士 紐澤西 UMDNJ Biomedical Informatics 博士 中研院博士後 台灣大學博士後